Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Stone

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Archives of General Psychiatry|May 4, 2011
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter studyAndrea Mechelli, Anita Riecher-Rössler, Eva M Meisenzahl, et al.
Schizophrenia Bulletin|January 3, 2018
Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second CohortPaul Allen, Matilda Azis, Gemma Modinos, et al.
Schizophrenia Bulletin|December 27, 2022
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging PhenotypesAmanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Schizophrenia Research|March 2, 2024
A letter to the editor: The effects of alcohol use on brain glutamate in first episode psychosisBridget King, Matthew J Kempton, Brian V Broberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosisCathy Davies, Grazia Rutigliano, Andrea De Micheli, et al.
Human Brain Mapping|October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosisGeorge Gifford, Nicolas Crossley, Sarah Morgan, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Archives of General Psychiatry|May 4, 2011
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter studyAndrea Mechelli, Anita Riecher-Rössler, Eva M Meisenzahl, et al.
Schizophrenia Bulletin|January 3, 2018
Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second CohortPaul Allen, Matilda Azis, Gemma Modinos, et al.
Schizophrenia Bulletin|December 27, 2022
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging PhenotypesAmanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Schizophrenia Research|March 2, 2024
A letter to the editor: The effects of alcohol use on brain glutamate in first episode psychosisBridget King, Matthew J Kempton, Brian V Broberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosisCathy Davies, Grazia Rutigliano, Andrea De Micheli, et al.
Human Brain Mapping|October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosisGeorge Gifford, Nicolas Crossley, Sarah Morgan, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Pageof 13